The Florida Department of Health has issued a statewide mosquito-borne illness advisory after four locally contracted cases of malaria were reported along the Gulf Coast south of Tampa.
The four residents in Sarasota County received treatment and have recovered, according to the state's Department of Health advisory. Malaria, caused by a parasite that spreads through bites from Anopheles mosquitoes, causes fever, chills, sweats, nausea and vomiting, and headaches. It is not spread person to person.
It's the threat of the mosquito-borne illness that concerns Kathleen Gibson-Dee, who lives on Terra Ceia Island, which is about 20 miles (32 kilometers) north of Sarasota County.
Even though no malaria cases have been reported in Manatee County, where Terra Ceia is located, Gibson-Dee said that she's now routinely using bug repellent while working in her garden.
“I don’t go out without it,” she told The Associated Press on Tuesday. “And we don't go out in the evening because you can see clouds and clouds of bugs now. They may not all be mosquitoes, but there’s certainly mosquitos out there.”
Another resident, Tom Lyons, says news of the malaria cases “makes me take mosquito protection a little more seriously."
The mosquito population thrives in Terra Ceia because "it's an island surrounded by a lot of shallow water and mangroves, and ideal places for mosquitoes,” Lyons said.
Officials in Manatee County have ramped up efforts to control the mosquito population.
Chris Lesser, director of the Manatee County mosquito control district, said they're primarily using helicopters to combat the mosquito population because they cover between 15,000 and 20,000 acres (6070 to 8082 hectares) in one night. A truck can only cover around 1,000 acres (404 hectares) a night, he said.
“We really want to focus on killing the adult mosquito before they have the opportunity to feed on one person that may be infected with malaria and then transmit that disease to a second person,” Lesser said.
He said the time frame for when a mosquito can become infected to when it can transmit the disease to a person is about 14 days.
“So we’re trying to get in there about once every seven to 10 days and really knock down the mosquito population. And that process will continue until the public health alert that we’re currently under is lifted,” Lesser said.
“It's a curtain,” he continued. “We're trying to keep the malaria mosquitos from coming into our county through our southern border by using aggressive mosquito control activities.”
Officials in Sarasota County area also using similar tactics to control mosquitos, the county's health department said in an advisory.
The initial malaria advisory was issued in Sarasota County after the first case was reported in late May. That was followed by a second case, and then two more, said Jae Williams, the press secretary for the Florida Department of Health.
“As soon as it crossed over from one to two confirmed cases, it progressed to an alert,” Williams said, comparing it to the system of issuing a hurricane watch versus a hurricane warning — when a storm is imminent.
“Listen, the conditions are favorable," Williams continued. "It's not just some rogue one mosquito. People need to be paying attention.”
Williams said health officials are being proactive.
“We know we are going into the Fourth of July holiday. We know the summer’s only getting hotter and wetter over the next couple of months,” Williams said. “So we just wanted to give Floridians a big kind of heads up, put the whole state on notice.”
About 2,000 U.S. cases of malaria are diagnosed each year — the vast majority in travelers coming from countries where malaria commonly spreads.
Since 1992, there have been 11 outbreaks involving malaria from mosquitoes in the U.S. The last one occurred in 2003 in Palm Beach County, Florida, where eight cases were reported.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
